NASDAQ:CMLT CM Life Sciences III (CMLT) Stock Price, News & Analysis → Urgent Nvidia Warning (From Altimetry) (Ad) Free CMLT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$8.29▼$9.1750-Day Range$8.69▼$9.9852-Week Range$8.29▼$11.10Volume563,420 shsAverage Volume284,659 shsMarket Capitalization$180.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get CM Life Sciences III alerts: Email Address Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy About CM Life Sciences IIICM Life Sciences III Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.Read More Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy CMLT Stock News HeadlinesMarch 8, 2024 | bizjournals.comNew life sciences initiative targets local industry growth, talent pipeline accelerationNovember 17, 2023 | benzinga.comTechnical Writing Excellence in the Life Sciences - A Masterclass (November 2-3, 2023)April 28, 2024 | Prosper Trading Academy (Ad)This AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?August 13, 2022 | bizjournals.comInterest in life sciences space in the Triangle remains intenseAugust 12, 2022 | msn.com(LEAD) Samsung Life Insurance Q2 net jumps 70.3 pctAugust 3, 2022 | apnews.comIpsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung CancerMay 17, 2022 | news.yahoo.comBaby formula available at Beginnings Care for Life Center in ColdwaterDecember 27, 2021 | reuters.comEQRx IncApril 28, 2024 | Prosper Trading Academy (Ad)This AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?December 19, 2021 | benzinga.comCM Life Sciences III Merger Partner EQRx Debuts On NasdaqDecember 2, 2021 | finance.yahoo.comEQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business CombinationNovember 29, 2021 | finance.yahoo.comEQRx to Present at the 4th Annual Evercore ISI HealthCONx ConferenceOctober 28, 2021 | wsj.comCM Life Sciences III Inc. Cl AOctober 6, 2021 | finance.yahoo.comEQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based DrugsSeptember 27, 2021 | finance.yahoo.comEQRx Appoints Kathy Giusti to Board of DirectorsSeptember 22, 2021 | nasdaq.comCM Life Sciences III Inc - Class A Shares Close in on 52-Week Low - Market MoverSeptember 13, 2021 | finance.yahoo.comEQRx Announces Presentation of Updated Data from Pivotal Phase 3 Study of Anti-PD-L1 Antibody Sugemalimab in Combination with Chemotherapy as a First-Line Treatment for Stage IV NSCLCSeptember 7, 2021 | finance.yahoo.comEQRx to Present at the Morgan Stanley 19th Annual Global Healthcare ConferenceAugust 28, 2021 | nasdaq.comCM Life Sciences III Inc - Class A Shares Approach 52-Week Low - Market MoverAugust 6, 2021 | nasdaq.comKeith Meister-backed SPAC to merge with biotech firm EQRx in $3.65 bln dealSee More Headlines Receive CMLT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CM Life Sciences III and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:CMLT CUSIPN/A CIK1843762 Webiii.cmlifesciencesspac.com Phone212-474-6745FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio1.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares20,725,000Free FloatN/AMarket Cap$180.10 million OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Eli Decatur CasdinCEO & DirectorMr. Brian Emes (Age 38)CFO & Sec. Dr. Shaun Kevin Rodriguez (Age 43)Chief Strategy Officer Key CompetitorsOmerosNASDAQ:OMERAlimera SciencesNASDAQ:ALIMVeruNASDAQ:VERUInventivaNASDAQ:IVACapricor TherapeuticsNASDAQ:CAPRView All Competitors This page (NASDAQ:CMLT) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyThe A.I. story nobody is telling you (Read ASAP)TradeSmithEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CM Life Sciences III Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
